Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β

被引:133
|
作者
Bingham, C
Ellard, S
Allen, L
Bulman, M
Shepherd, M
Frayling, T
Berry, PJ
Clark, PM
Lindner, T
Bell, GI
Ryffel, GU
Nicholls, AJ
Hattersley, AT
机构
[1] Univ Exeter, Dept Vasc Med & Diabet Res, Sch Postgrad Med & Hlth Sci, Exeter EX2 5AX, Devon, England
[2] Univ Essen Gesamthsch Klinikum, Inst Zellbiol Tumorforsch, D-4300 Essen, Germany
[3] Bristol Royal Hosp Sick Children, Paediat Pathol Dept, Bristol, Avon, England
[4] Univ Hosp Birmingham, NHS Trust, Reg Endocrine Lab, Birmingham, W Midlands, England
[5] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA
[6] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA
[7] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[8] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
基金
英国医学研究理事会;
关键词
cystic kidney; diabetes mellitus; genetics; transcription factors; embryology; nephrogenesis;
D O I
10.1046/j.1523-1755.2000.057003898.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The transcription factor hepatocyte nuclear factor (HNF)-1 beta functions as a homodimer or as a heterodimer with the structurally related protein HNF-1 alpha. Both are expressed sequentially in rat kidney development, with HNF-1 beta being detected from the earliest inductory phases. HNF-1 beta gene mutations are associated with a unique disorder characterized by maturity-onset diabetes of the young (MODY) and early-onset and progressive nondiabetic renal dysfunction, which may lead to chronic renal failure. Methods. The HNF-1 beta gene was screened for mutations in six subjects with early-onset diabetes and a history of renal dysfunction in the subjects or their families. Results. A novel frameshift mutation in exon 4 of the HNF-1 beta gene and a deletion of CCTCT at codons 328 to 329 were detected in one subject. She was diagnosed as diabetic at the age of 21 in her second pregnancy. Glucose tolerance rapidly deteriorated over 18 months as a result of beta-cell dysfunction. The HNF-1 beta mutation arose de novo on a paternal chromosome and cosegregated with renal abnormalities in her family. The proband had bilateral small cysts in normal-sized kidneys and a reduced creatinine clearance of 66 mL/min (NR 80-120). Her first pregnancy was terminated at 17 weeks following an ultrasound diagnosis of bilateral, nonfunctioning cystic kidneys. Her first-born child had a small multicystic. dysplastic right kidney and a dysplastic let kidney with a reduced creatinine clearance (40 mL/min per 1.73 m(2)). Histologic examination of the large (5.8 vs. 1.4 g), polycystic fetal kidneys showed no normal nephrogenesis. Conclusions. These studies indicate that HNF-1 beta plays a central role in normal kidney development and pancreatic beta-cell function. and suggest that one mechanism by which HNF-1 beta gene mutations may cause renal dysfunction are by their effects on nephron development.
引用
收藏
页码:898 / 907
页数:10
相关论文
共 50 条
  • [1] A frameshift mutation in hepatocyte nuclear factor 1β cause diabetes by β cell dysfunction and renal dysfunction by abnormal nephron development
    Hattersley, AT
    Bingham, C
    Shepard, M
    Allen, LI
    Berry, P
    Bulman, M
    Frayling, TM
    Ellard, S
    DIABETES, 1999, 48 : A33 - A33
  • [2] Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1β gene associated with diabetes and renal dysfunction
    Nishigori, H
    Yamada, S
    Kohama, T
    Tomura, H
    Sho, K
    Horikawa, Y
    Bell, GI
    Takeuchi, T
    Takeda, J
    DIABETES, 1998, 47 (08) : 1354 - 1355
  • [3] Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative
    Yamagata, K
    Yang, Q
    Yamamoto, K
    Iwahashi, H
    Miyagawa, J
    Okita, K
    Yoshiuchi, I
    Miyazaki, J
    Noguchi, T
    Nakajima, H
    Namba, M
    Hanafusa, T
    Matsuzawa, Y
    DIABETES, 1998, 47 (08) : 1231 - 1235
  • [4] Structure/function studies of hepatocyte nuclear factor-1α, a diabetes-associated transcription factor
    Yang, Q
    Yamagata, K
    Yamamoto, K
    Miyagawa, J
    Takeda, J
    Iwasaki, N
    Iwahashi, H
    Yoshiuchi, I
    Namba, M
    Miyazaki, J
    Hanafusa, T
    Matsuzawa, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (01) : 196 - 202
  • [5] Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease
    Shao, Annie
    Chan, Siu Chiu
    Igarashi, Peter
    CELLULAR SIGNALLING, 2020, 71
  • [6] Transcription Factor Hepatocyte Nuclear Factor-1β Regulates Renal Cholesterol Metabolism
    Aboudehen, Karam
    Kim, Min Soo
    Mitsche, Matthew
    Garland, Kristina
    Anderson, Norma
    Noureddine, Lama
    Pontoglio, Marco
    Patel, Vishal
    Xie, Yang
    DeBose-Boyd, Russell
    Igarashi, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (08): : 2408 - 2421
  • [7] Hepatocyte nuclear factor 1β controls nephron tubular development
    Massa, Filippo
    Garbay, Serge
    Bouvier, Raymonde
    Sugitani, Yoshinobu
    Noda, Tetsuo
    Gubler, Marie-Claire
    Heidet, Laurence
    Pontoglio, Marco
    Fischer, Evelyne
    DEVELOPMENT, 2013, 140 (04): : 886 - 896
  • [8] Hepatocyte nuclear factor-1 alpha regulates transcription of the guanylin gene
    Hochman, JA
    Sciaky, D
    Whitaker, TL
    Hawkins, JA
    Cohen, MB
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (04): : G833 - G841
  • [9] Clinical spectrum associated with hepatocyte nuclear factor-1β mutations
    Bellanné-Chantelot, C
    Chauveau, D
    Gautier, JF
    Dubois-Laforgue, D
    Clauin, S
    Beaufils, S
    Wilhelm, JM
    Boitard, C
    Noël, LH
    Velho, G
    Timsit, J
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (07) : 510 - 517
  • [10] Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation
    Bingham, C
    Ellard, S
    van't Hoff, WG
    Simmonds, HA
    Marinaki, AM
    Badman, MK
    Winocour, PH
    Stride, A
    Lockwood, CR
    Nicholls, AJ
    Owen, KR
    Spyer, G
    Pearson, ER
    Hattersley, AT
    KIDNEY INTERNATIONAL, 2003, 63 (05) : 1645 - 1651